Why Steve Aselage Unloaded 2,130 Shares of Retrophin, Inc. (RTRX)?; Agnico Eagle Mines Limited (AEM) SI Decreased By 25.9%

Agnico Eagle Mines Limited (NYSE:AEM) Logo

Agnico Eagle Mines Limited (NYSE:AEM) had a decrease of 25.9% in short interest. AEM’s SI was 4.84M shares in February as released by FINRA. Its down 25.9% from 6.53 million shares previously. With 1.34 million avg volume, 4 days are for Agnico Eagle Mines Limited (NYSE:AEM)’s short sellers to cover AEM’s short positions. The stock decreased 0.93% or $0.39 during the last trading session, reaching $41.62. About 708,169 shares traded. Agnico Eagle Mines Limited (NYSE:AEM) has declined 7.00% since February 14, 2018 and is downtrending. It has underperformed by 7.00% the S&P500. Some Historical AEM News: 26/04/2018 – AGNICO EAGLE MINES LTD – PRODUCTION AND COST GUIDANCE REITERATED FOR 2018; 22/03/2018 – Pöyry awarded EPCM services assignment for expansion investment of Agnico Eagle Finland gold mine in Kittilä, Finland; 30/04/2018 – Agnico Eagle Mines: Each of 10 Nominees Elected as Directors; 26/04/2018 – AGNICO EAGLE MINES LTD – HAS INITIATED A STRATEGIC REVIEW OF ITS COBALT PROPERTIES; 25/04/2018 – AEM Holdings Closes Below 50-Day Moving Average: Technicals; 26/04/2018 – AGNICO EAGLE MINES – NEWMONT TO PURCHASE AGNICO EAGLE’S 51% INTEREST IN WEST PEQUOP JV, CO’S INTEREST IN SUMMIT & PQX PROPERTIES IN NORTHEASTERN NEVADA; 24/04/2018 – AEM HOLDINGS LTD AEM.Sl – REITERATE GUIDANCE FOR FY2018 OF AT LEAST S$255 MILLION SALES AND S$42 MILLION PROFIT BEFORE TAX; 14/05/2018 – Metalla Adds Royalty on Agnico Eagle’s Akasaba West Development Project; 26/04/2018 – AGNICO EAGLE MINES – EXPECTS STRATEGIC REVIEW MAY RESULT IN SALE OF ALL OR A PORTION OF ITS COBALT PROPERTIES; 07/03/2018 Singapore Bourse: Change In Aem Holdings Ltd

The stock decreased 3.47% or $0.77 during the last trading session, reaching $21.44. About 255,037 shares traded. Retrophin, Inc. (NASDAQ:RTRX) has risen 11.46% since February 14, 2018 and is uptrending. It has outperformed by 11.46% the S&P500.

Among 3 analysts covering Retrophin (NASDAQ:RTRX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Retrophin has $57 highest and $36 lowest target. $45.67’s average target is 113.01% above currents $21.44 stock price. Retrophin had 3 analyst reports since August 17, 2018 according to SRatingsIntel.

Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. The company has market cap of $884.35 million. The Company’s marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of patients with peroxisomal disorders; and Thiola, a tiopronin tablet for the treatment of cystinuria. It currently has negative earnings. The company??s product candidates consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis; Fosmetpantotenate, a novel small molecule that is in Phase III clinical trial to treat pantothenate kinase-associated neurodegeneration; Tetracosactide Zinc , a synthetic hormone analog that is in preclinical stage; and Liquid Ursodeoxycholic Acid, a liquid formulation of ursodeoxycholic acid, which is in preclinical stage to treat primary biliary cholangitis.

Analysts await Retrophin, Inc. (NASDAQ:RTRX) to report earnings on February, 26. They expect $-0.62 earnings per share, down 58.97% or $0.23 from last year’s $-0.39 per share. After $-1.34 actual earnings per share reported by Retrophin, Inc. for the previous quarter, Wall Street now forecasts -53.73% EPS growth.

Since August 31, 2018, it had 0 insider buys, and 11 sales for $2.03 million activity. The insider ASELAGE STEVE sold $266,703. Clague Laura had sold 7,500 shares worth $180,138 on Wednesday, November 14. McFarlane Neil F. sold $248,333 worth of stock or 11,125 shares. REED ELIZABETH E sold $35,933 worth of stock or 1,500 shares. ROTE WILLIAM E. had sold 5,000 shares worth $120,130.

Investors sentiment decreased to 1.08 in Q3 2018. Its down 0.24, from 1.32 in 2018Q2. It dropped, as 16 investors sold Retrophin, Inc. shares while 34 reduced holdings. 22 funds opened positions while 32 raised stakes. 41.12 million shares or 2.80% more from 40.01 million shares in 2018Q2 were reported. Connor Clark Lunn Inv Mngmt Limited invested in 13,150 shares. California Public Employees Retirement System owns 0% invested in Retrophin, Inc. (NASDAQ:RTRX) for 68,094 shares. Qs Invsts Limited Company invested in 0% or 137 shares. Jane Street Grp Limited Liability invested in 0% or 79,920 shares. Hartford Inv reported 7,442 shares. Tiaa Cref Investment Limited Liability Corporation holds 0.01% of its portfolio in Retrophin, Inc. (NASDAQ:RTRX) for 581,522 shares. California State Teachers Retirement System accumulated 61,896 shares or 0% of the stock. Schwab Charles Investment Mgmt, California-based fund reported 269,268 shares. Sectoral Asset Mngmt Inc holds 10,036 shares or 0.03% of its portfolio. Fmr Limited Liability Company owns 831,928 shares for 0% of their portfolio. Boston Advsr Llc stated it has 79,947 shares or 0.1% of all its holdings. Panagora Asset Mgmt holds 0.01% in Retrophin, Inc. (NASDAQ:RTRX) or 54,910 shares. Mackay Shields Limited Liability Corp holds 0.01% of its portfolio in Retrophin, Inc. (NASDAQ:RTRX) for 23,100 shares. 263,900 were reported by Spark Inv Mgmt. Zurcher Kantonalbank (Zurich Cantonalbank) invested in 2,838 shares or 0% of the stock.

More notable recent Retrophin, Inc. (NASDAQ:RTRX) news were published by: Nasdaq.com which released: “Retrophin to Report Fourth Quarter and Full Year 2018 Financial Results – Nasdaq” on February 12, 2019, also Nasdaq.com with their article: “Analysis: Positioning to Benefit within Amarin, Retrophin, Sunrun, BioSpecifics Technologies, Arbutus Biopharma, and TOCAGEN INC — Research Highlights Growth, Revenue, and Consolidated Results – Nasdaq” published on February 04, 2019, Seekingalpha.com published: “New chief at Retrophin – Seeking Alpha” on January 03, 2019. More interesting news about Retrophin, Inc. (NASDAQ:RTRX) were released by: Globenewswire.com and their article: “Retrophin Provides Corporate Update and 2019 Outlook Nasdaq:RTRX – GlobeNewswire” published on January 07, 2019 as well as Benzinga.com‘s news article titled: “The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive – Benzinga” with publication date: January 29, 2019.

Steve Aselage, an insider, who is at present the Chief Executive Officer of Retrophin Inc made a sale of just 2,130 shares of the firm that are worth about $45,667 US Dollars at an average 21.4 US Dollars for a share. In the last 30 days, he also unloaded 2,130 shares with a total value of about $45,667 USD. Steve Aselage right now owns 257,642 shares or 0.62% of Retrophin Inc’s market cap. A Form 4 on hand for review here shows this insider activity, that was conducted on 13/02/2019 and was filed with the SEC.

More notable recent Agnico Eagle Mines Limited (NYSE:AEM) news were published by: Benzinga.com which released: “Earnings Scheduled For February 14, 2019 – Benzinga” on February 14, 2019, also Fool.ca with their article: “Building Canadian Wealth: Start Your Diversified TFSA Portfolio With These 5 Top Stocks – The Motley Fool Canada” published on February 10, 2019, Seekingalpha.com published: “Newmont CEO defends Goldcorp deal but analyst foresees rival bidders – Seeking Alpha” on January 15, 2019. More interesting news about Agnico Eagle Mines Limited (NYSE:AEM) were released by: Benzinga.com and their article: “26 Stocks Moving In Monday’s Pre-Market Session – Benzinga” published on February 11, 2019 as well as Investorplace.com‘s news article titled: “3 of the Best Gold Stocks to Mine for Cash – Investorplace.com” with publication date: January 28, 2019.

Among 3 analysts covering Agnico Eagle Mines (NYSE:AEM), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Agnico Eagle Mines had 3 analyst reports since August 29, 2018 according to SRatingsIntel. The rating was maintained by Citigroup with “Neutral” on Wednesday, August 29. The stock has “Overweight” rating by JP Morgan on Monday, September 17.

Retrophin, Inc. (NASDAQ:RTRX) Institutional Positions Chart